Syros Pharmaceuticals (SYRS) Earnings
|
Expand Research on SYRS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +40.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/25/26  |
Q425 | N/A | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/24/25 |
Q325 | N/A | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/20/25 |
Q325 | N/A | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/18/25 |
Q325 | N/A | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/25/25 |
Q325 | N/A | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/15/25 |
Q225 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 7/31/25 |
Q225 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/4/25 |
Q225 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A |
